Articles published by Coherus BioSciences, Inc.
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
March 05, 2024
Via GlobeNewswire
Tickers
CHRS
Coherus Completes Divestiture of Ophthalmology Franchise
March 04, 2024
Via GlobeNewswire
Tickers
CHRS
Coherus BioSciences Announces New Employment Inducement Grants
February 23, 2024
Via GlobeNewswire
Tickers
CHRS
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
February 05, 2024
Via GlobeNewswire
Tickers
CHRS
Coherus BioSciences Management to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
Via GlobeNewswire
Tickers
CHRS
Via GlobeNewswire
Tickers
CHRS
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
November 06, 2023
Via GlobeNewswire
Tickers
CHRS
Via GlobeNewswire
Tickers
CHRS
Coherus BioSciences to Report Third Quarter 2023 Financial Results on November 6, 2023
October 30, 2023
Via GlobeNewswire
Tickers
CHRS
Coherus BioSciences Announces New Employment Inducement Grants
October 24, 2023
Via GlobeNewswire
Tickers
CHRS
Coherus Announces Resubmission of Biologics License Application (BLA) Supplement for UDENYCA® ONBODY™
October 05, 2023
Via GlobeNewswire
Tickers
CHRS
Via GlobeNewswire
Tickers
CHRS
Via GlobeNewswire
Tickers
CHRS
Coherus Announces Three Presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
September 27, 2023
Via GlobeNewswire
Tickers
CHRS
Via GlobeNewswire
Tickers
CHRS
Coherus BioSciences Announces New Employment Inducement Grants
September 22, 2023
Via GlobeNewswire
Tickers
CHRS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.